Literature DB >> 11467047

Motor neuron disease: classification and nomenclature.

M Swash1, J Desai.   

Abstract

The classification and nomenclature of motor neuron disease, whether sporadic or familial, is confused. For example, both the sporadic and familial motor neuron diseases are phenotypically heterogeneous and, in familial ALS, phenotypic heterogeneity correlates only weakly with different underlying mutations in the SOD1 gene. We propose a classification which is based on underlying causative mechanisms, where these are known, but which also recognizes different clinical phenotypes when the cause is unknown. This classification is flexible, and allows reattribution of clinical syndromes when their causation is understood. Currently uncertain associations--for example, a possible association of ALS with cancer--are given tentative recognition in this classification. In addition, this new classification recognizes geographical clustering and descriptions of unusual motor neuron disorder phenotypes of unknown origin in different parts of the world.

Entities:  

Mesh:

Year:  2000        PMID: 11467047     DOI: 10.1080/14660820050515403

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  7 in total

1.  [Provision of assistive devices in amyotrophic lateral sclerosis. Analysis of 3 years case management in an internet-based supply network].

Authors:  A Funke; T Grehl; J Großkreutz; C Münch; B Walter; D Kettemann; C Karnapp; N Gajewski; R Meyer; A Maier; K M Gruhn; T Prell; K Kollewe; S Abdulla; X Kobeleva; S Körner; S Petri; T Meyer
Journal:  Nervenarzt       Date:  2015-08       Impact factor: 1.214

Review 2.  Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease.

Authors:  Jeffrey Rosenfeld; Michael J Strong
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

3.  Strictly monitored exercise programs reduce motor deterioration in ALS: preliminary results of a randomized controlled trial.

Authors:  Christian Lunetta; Andrea Lizio; Valeria A Sansone; Nadia Maria Cellotto; Eleonora Maestri; Massimo Bettinelli; Valentina Gatti; Mario Giovanni Melazzini; Giovanni Meola; Massimo Corbo
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

4.  Electrophysiological properties of motor neurons in a mouse model of severe spinal muscular atrophy: in vitro versus in vivo development.

Authors:  Hongmei Zhang; Natallia Robinson; Chiayen Wu; Wenlan Wang; Melissa A Harrington
Journal:  PLoS One       Date:  2010-07-21       Impact factor: 3.240

Review 5.  Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease.

Authors:  Vanina Dal Bello-Haas; Julaine M Florence
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31

6.  Latent cluster analysis of ALS phenotypes identifies prognostically differing groups.

Authors:  Jeban Ganesalingam; Daniel Stahl; Lokesh Wijesekera; Clare Galtrey; Christopher E Shaw; P Nigel Leigh; Ammar Al-Chalabi
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

7.  Defective Ca2+ channel clustering in axon terminals disturbs excitability in motoneurons in spinal muscular atrophy.

Authors:  Sibylle Jablonka; Marcus Beck; Barbara Dorothea Lechner; Christine Mayer; Michael Sendtner
Journal:  J Cell Biol       Date:  2007-10-08       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.